Valuation
Market cap
$177.2B
P/E (ttm)
22.8
Forward P/E
14.0
Beta (5y)
0.43
Shares out
539.7M
Div yield
307.00%
Profitability & returns
ROE
101.3%
Net margin
21.0%
FCF margin
20.0%
Debt / equity
6.24
Trading information
Last price
$328.26
Day range
$328.26 – $328.26
52-wk range
$312.39 – $391.29
Avg volume
2.6M
RSI (2)
4.5
TAO zone
Pullback
Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NMS
Next earnings
2026-08-04
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEV…